Medtronic had 25 patents in batteries during Q2 2024. Medtronic Plc has filed patents for innovative batteries with high energy discharge rates, devices for delivering pacing pulses in the atrium, electrical devices with memory for monitoring battery capacity, and electrochemical cells with over-discharge protection and gelling electrolytes. GlobalData’s report on Medtronic gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Medtronic had no grants in batteries as a theme in Q2 2024.
Recent Patents
Application: Feedthrough insulator cap for medical device battery (Patent ID: US20240173556A1)
The patent filed by Medtronic Plc describes a battery designed to support high rates of energy discharge for energy-intensive therapy delivery. The battery includes a feedthrough insulator cap that reduces dendrite formation on the ferrule and pin, along with electrodes and an electrolyte within the enclosure. The feedthrough insulator cap prevents dendrite formation during battery operation, ensuring efficient performance.
Furthermore, the patent outlines specific claims related to the design and components of the battery, including the feedthrough insulator cap's structure and functionality. The battery is particularly suitable for high-rate primary lithium metal batteries used in medical devices. The design elements, such as the brim and crown of the insulator cap, play a crucial role in preventing dendrite formation and ensuring the battery's reliability and longevity in powering electronic components of medical devices.
To know more about GlobalData’s detailed insights on Medtronic, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.